In human cholangiocarcinoma cells, G9a and H3K9me2 levels are increased at the promoter region of the LATS2 gene, which promotes its repression, while G9a knockdown increases LATS2 expression and reduces YAP nuclear localization [33]. Here, LATS2 is linked to cholangiocarcinoma.